Transdermal Drug Delivery Systems (TDDS) are a large and growing vertical market of the pharmaceutical industry. Lydall identified the need for an effective transdermal drug delivery membrane and introduced a next generation medically approved polymer specifically designed to be used as a substrate through which liquid, cream, or oil can be released in a controlled manner.
Lydall’s family of Solupor® membrane provides an ideal format for transdermal drug delivery, as it is highly inert and allows for controlled permeability. The membrane is comprised of a microporous polyethylene film, which has consistent internal strength and is highly porous to ensure both durability and reliable drug delivery. Solupor membrane’s biocompatible qualities, combined with a unique pore size make it suitable for materials in a range of multi-layer transdermal drug-in-adhesive and reservoir applications.